{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:15:38Z","timestamp":1704932138585},"reference-count":15,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n<jats:title \/>\n<jats:p \/>\n<\/jats:sec>","DOI":"10.2174\/1570161120666220413094635","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T05:27:58Z","timestamp":1650000478000},"page":"318-320","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antithrombotic Therapy After TAVI: Evidence, Discordance, and Clinical\nImplications"],"prefix":"10.2174","volume":"20","author":[{"given":"Felice","family":"Gragnano","sequence":"first","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Naples, Italy"},{"name":"Division of\nCardiology, A.O.R.N. \u201cSant\u2019Anna e San Sebastiano\u201d, Caserta, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Cesaro","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Naples, Italy"},{"name":"Division of\nCardiology, A.O.R.N. \u201cSant\u2019Anna e San Sebastiano\u201d, Caserta, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, Naples, Italy"},{"name":"Division of\nCardiology, A.O.R.N. \u201cSant\u2019Anna e San Sebastiano\u201d, Caserta, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"Vahanian A.","year":"2022","unstructured":"Vahanian A.; Beyersdorf F.; Praz F.; ESC\/EACTS Scientific document group, ESC scientific document group. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J ESC\/EACTS Scientific Document Group2022,43(7),561-632","journal-title":"Eur Heart J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","volume":"143","author":"Otto C.M.","year":"2021","unstructured":"Otto C.M.; Nishimura R.A.; Bonow R.O.; 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: A report of the american college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 2021,143(5),e72-e227","journal-title":"Circulation"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.121.054305","volume":"144","author":"Calabr&#xF2; P.","year":"2021","unstructured":"Calabr&#xF2; P.; Gragnano F.; Niccoli G.; Antithrombotic therapy in patients undergoing transcatheter interventions for structural heart disease. Circulation 2021,144(16),1323-1343","journal-title":"Circulation"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jacc.2020.11.046","volume":"77","author":"Leonardi S.","year":"2021","unstructured":"Leonardi S.; Gragnano F.; Carrara G.; Prognostic implications of declining hemoglobin content in patients hospitalized with acute coronary syndromes. J Am Coll Cardiol 2021,77(4),375-388","journal-title":"J Am Coll Cardiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e898","DOI":"10.4244\/EIJ-D-21-00181","volume":"17","author":"Gragnano F.","year":"2021","unstructured":"Gragnano F.; Spirito A.; Corpataux N.; Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition. EuroIntervention 2021,17(11),e898-e909","journal-title":"EuroIntervention"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/ehjcvp\/pvaa106","volume":"8","author":"Gragnano F.","year":"2022","unstructured":"Gragnano F.; Heg D.; Franzone A.; PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: Insights from the GLOBAL LEADERS and GLASSY. Eur Heart J Cardiovasc Pharmacother 2022,8(1),28-38","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/eurheartj\/ehy675","volume":"40","author":"Gragnano F.","year":"2019","unstructured":"Gragnano F.; Calabr&#xF2; P.; Valgimigli M.; Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention? Eur Heart J 2019,40(2),216-217","journal-title":"Eur Heart J"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","volume":"383","author":"Brouwer J.","year":"2020","unstructured":"Brouwer J.; Nijenhuis V.J.; Delewi R.; Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 2020,383(15),1447-1457","journal-title":"N Engl J Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","volume":"42","author":"Ten Berg J.","year":"2021","unstructured":"Ten Berg J.; Sibbing D.; Rocca B.; Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: A consensus document of the ESC working group on Thrombosis and the European Association of Percutaneous Cardiovascular interventions (EAPCI), in collaboration with the ESC council on valvular heart disease. Eur Heart J 2021,42(23),2265-2269","journal-title":"Eur Heart J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"n1332","DOI":"10.1136\/bmj.n1332","volume":"373","author":"Valgimigli M.","year":"2021","unstructured":"Valgimigli M.; Gragnano F.; Branca M.; P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: Individual patient level meta-analysis of randomised controlled trials. BMJ 2021,373(1332),n1332","journal-title":"BMJ"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijcard.2021.10.138","volume":"345","author":"Cesaro A.","year":"2021","unstructured":"Cesaro A.; Gragnano F.; Calabr&#xF2; P.; Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry. Int J Cardiol START-ANTIPLATELET collaborators2021,345,7-13","journal-title":"Int J Cardiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1911425","volume":"382","author":"Dangas G.D.","year":"2020","unstructured":"Dangas G.D.; Tijssen J.G.P.; W&#xF6;hrle J.; A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med GALILEO Investigators2020,382(2),120-129","journal-title":"N Engl J Med"},{"key":"ref=13","author":"Collet J.P.","unstructured":"Collet J.P.; Anti-thrombotic strategy to lower all cardiovascular and neurologic ischemic and hemorrhagic events after trans-aortic valve implantation for aortic stenosis - ATLANTIS. American College of Cardiology (ACC) Virtual Annual Scientific Session Available from: .","journal-title":"American College of Cardiology (ACC) Virtual Annual Scientific Session"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","volume":"382","author":"Nijenhuis V.J.","year":"2020","unstructured":"Nijenhuis V.J.; Brouwer J.; Delewi R.; Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 2020,382(18),1696-1707","journal-title":"N Engl J Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","volume":"385","author":"Van Mieghem N.M.","year":"2021","unstructured":"Van Mieghem N.M.; Unverdorben M.; Hengstenberg C.; ENVISAGE-TAVI AF Investigators. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR. N Engl J Med 2021,385(23),2150-2160","journal-title":"N Engl J Med"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570161120666220413094635","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/203485\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570161120666220413094635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T15:36:46Z","timestamp":1704901006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/203485\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570161120666220413094635","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}